Clinical Research Directory
Browse clinical research sites, groups, and studies.
Bioresorbable Airway Splint Pivotal Clinical Trial
Sponsor: University of Michigan
Summary
The purpose of this study is to learn if a three-dimensional (3D) printed airway splint device made to hold open a collapsing airway is a safe and effective treatment of Tracheobronchomalacia (TBM) in children. The airway splint is bioresorbable, meaning the child's body will absorb the splint over about five years.
Official title: A Multi-Center Trial to Assess the Safety and Effectiveness of a Bioresorbable Tracheobronchial Splint in Pediatric Subjects With Clinically Significant Tracheobronchomalacia
Key Details
Gender
All
Age Range
1 Week - 3 Years
Study Type
INTERVENTIONAL
Enrollment
35
Start Date
2025-01-07
Completion Date
2034-03
Last Updated
2026-01-21
Healthy Volunteers
No
Conditions
Interventions
Bioresorbable Tracheobronchial Splint
Subjects will have several imaging and bronchoscopic studies and the placement of the splint will require an open-chest surgery to implant the airway splint (s). The Materialise Bioresorbable Tracheobronchial Splint is designed for an individual subject based on Computed Tomography (CT) scans taken using a specific scan protocol. Based on these 3D models, a pre-operative plan is discussed between the Materialise engineering team and the treating surgeon(s) to determine the locations and required dimensions of the splint(s). Each subject may receive up to four splints positioned on subject's trachea or mainstem bronchi. Subjects will also have several follow-up visits, and parents will be expected to regularly fill out questionnaires.
Locations (1)
University of Michigan
Ann Arbor, Michigan, United States